<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_XJTLU-CHINA_RNA_Stabilization skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:XJTLU-CHINA/RNA Stabilization</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container"><NAV class="navbar navbar-default navbar-fixed-top" style="box-shadow: 1px 2px 4px rgba(43,43,43,0.5); margin-bottom: 0px"><DIV class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav"><LI style="margin-left: 100px"><A href="https://2018.igem.org/Team:XJTLU-CHINA">Home</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Exosome_Biogenesis">Exosome Biogenesis</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/RNA_Packaging">RNA Packaging</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Targeting_And_Delivery">Targeting and Delivery</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/RNA_Stabilization">RNA Stabilization</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Demonstrate">Results</A></LI></UL><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Modeling </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Model">Our Model</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Modelling1">Pharmacokinetic model</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Modelling2">mRNA delivery simulation</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Modelling3">Functional exosome production system</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Human Practice</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/HP/Silver">Silver</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/HP/Gold">Gold</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Education">Education</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Survey_And_Policy">Survey and Policy</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Notebook </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Labbook">Lab Book</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Protocols">Protocols</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Parts </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Basic_Part">Basic Parts</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Composite_Part">Composite Parts</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Team </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Team">Members</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Attributions">Attribution</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Safety">Safety</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/InterLab">InterLab</A></LI></DIV></DIV></NAV></DIV><DIV class="container-fluid" style="background-color: rgb(84,146,197); padding: 40px 30px; margin-top: 35px"><H1 style="font-family:'Impact'; color: white; font-size: 80px; margin-top: 20px; margin-bottom: 50px; float: left; margin-left: 20px">
        RNA Stabilization
    </H1><DIV class="container-fluid" style="background-color: white; box-shadow: 0px 0px 4px rgba(0,0,0,0.56); border-radius: 5px; margin-top: 200px; padding-bottom: 50px"><DIV class="row" style="margin-top: 60px"><DIV class="col-xs-10"><H2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">Design overview</H2><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    We inserted a 4x RNA stabilizing sequence derived from Venezuelan equine encephalitis virus (VEEV RTSS in short) at the 3’ UTR region of the mRNA construct.
                    With the assistance of the former three designs (in Exosome biogenesis, RNA packaging &amp; RNA delivery),
                    the therapeutic RNA transcript with 4x VEEV RTSS is integrated into the exosomes and delivered into neurons in the central nervous system,
                    thereafter expressing its therapeutic gene for a prolonged time period.
                </P></DIV></DIV><DIV class="row" style="margin-top: 20px"><DIV class="col-xs-10"><H2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">Aim of the design</H2><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    Intracellular delivery and stability are two major obstacles for mRNA-based therapy (Kaczmarek, Kowalski &amp; Anderson, 2017).
                    Quite a few RNA molecules have been substantiated to be therapeutically effective in vitro but fail to function appreciably in vivo,
                    which is largely ascribed to their limited half-life and delivery method.
                    Therefore,
                    we manage to solve the RNA intracellular stability issue by attaching the RNA stabilizing element from VEEV to the 3’ UTR of various therapeutic RNA transcripts.
                </P></DIV></DIV><DIV class="row" style="margin-top: 20px"><DIV class="col-xs-10"><H2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">VEEV RTSS</H2><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    This sequence is derived from the 3’ UTR of the single-stranded RNA virus VEEV upstream of its poly A tail (Garneau, et al., 2008).
                    The specific function of this sequence in the virus is still not fully uncovered. However,
                    according to the Hayashi’s research group (2010),
                    adding this element to the 3’ end of any protein-encoding sequence could prolong the expression duration. Moreover,
                    they also observed an enhanced RNA stabilizing capacity by arranging it in multiple repeats.
                    The stabilizing mechanism demonstrated by the Hayashi’s group (2010) is that the sequence can impede the poly A shortening process mediated by deadenylase enzymes,
                    which is thought to be the major RNA decay pathway (Houseley &amp; Tollervey, 2009).
                    A 38-kiloDalton protein in mammalian cells was reported to be involved in this block of deadenylation,
                    however the identity of this protein still remains unspecified (Garneau, et al., 2008).
                </P><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    Hayashi et al (2010) tested the stabilizing abilities of different configurations of this sequence.
                    From the results of Hayashi’s study,
                    4x VEEV RTSS appeared to be most capable of prolonging mRNA expression (see the figure below).
                    Hence, in the iGEM project, we adopt using 4 copies of the VEEV sequence as our mRNA stabilizer.
                </P></DIV></DIV><DIV class="row" style="margin-top: 20px"><DIV class="col-xs-6" style="text-align: center"><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    Hayashi et al (2010) [Online] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/
                </P></DIV></DIV><DIV class="row" style="margin-top: 20px"><DIV class="col-xs-10"><H2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">Design of testing</H2></DIV></DIV><DIV class="row" style="margin-top: 20px"><DIV class="col-xs-10"><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    We constructed three plasmids for the RNA stabilization test.
                    The L7Ae protein and C/D box (belonging to the RNA packaging part) are also involved in this test to ensure that after purifying exosomes by ultracentrifugation,
                    there is detectable amount of RNA packaged in the exosomes for its expression in target neurons.
                </P><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px"><STRONG>1. Co-transfection of HEK293T cells.</STRONG></P><TABLE class="table" style="border-right: 1px solid rgba(0,0,0,0.1); border-left: 1px solid rgba(0,0,0,0.1); border-bottom: 1px solid rgba(0,0,0,0.1)"><TBODY><TR><TH style="text-align: center">pcDNA3.1-CD63-nanoluc</TH><TH style="text-align: center">pcDNA3.1-STEAP3-IRES-SDC4-IRES-NadB</TH><TH style="text-align: center">pcDNA3.1-nSMase</TH></TR><TR><TH>Group 1</TH><TH style="font-weight: 400; text-align: center">+</TH><TH style="font-weight: 400; text-align: center">-</TH><TH style="font-weight: 400; text-align: center">-</TH></TR><TR><TH>Group 2</TH><TH style="font-weight: 400; text-align: center">+</TH><TH style="font-weight: 400; text-align: center">+</TH><TH style="font-weight: 400; text-align: center">-</TH></TR><TR><TH>Group 3</TH><TH style="font-weight: 400; text-align: center">+</TH><TH style="font-weight: 400; text-align: center">+</TH><TH style="font-weight: 400; text-align: center">+</TH></TR><TR><TH>Group 4</TH><TH style="font-weight: 400; text-align: center">+</TH><TH style="font-weight: 400; text-align: center">-</TH><TH style="font-weight: 400; text-align: center">+</TH></TR></TBODY></TABLE><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    After co-transfection, exosomes are collected through ultracentrifugation.
                </P><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px"><STRONG>2. Application of the collected exosomes to the neuronal cells.</STRONG></P><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px"><STRONG>3. The mRNA stabilizing ability (protein expression prolonging ability) is estimated by using luciferase assay over a time course.</STRONG></P></DIV></DIV><DIV style="text-align: center; margin-top: 50px; border-bottom: 0.8px solid #337ab7; padding-bottom: 20px"><H1 style="font-family:'Impact'; color: #337ab7">
                References
            </H1></DIV><DIV class="row" style="margin-bottom: 40px"><DIV class="col-xs-10"><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    Garneau, N. L., Sokoloski, K. J., Opyrchal, M., Neff, C. P., Wilusz, C. J., and Wilusz, J. (2008) The 3' untranslated region of sindbis virus represses deadenylation of viral transcripts in mosquito and Mammalian cells. Journal of virology 82, 880-892
                </P><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    Hayashi, T., Lamba, D. A., Slowik, A., Reh, T. A., and Bermingham-McDonogh, O. (2010) A method for stabilizing RNA for transfection that allows control of expression duration. Developmental dynamics : an official publication of the American Association of Anatomists 239, 2034-2040
                </P><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    Houseley, J., and Tollervey, D. (2009) The many pathways of RNA degradation. Cell 136, 763-776
                </P><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    Kaczmarek, J. C., Kowalski, P. S., and Anderson, D. G. (2017) Advances in the delivery of RNA therapeutics: from concept to clinical reality. Genome medicine 9, 60
                </P></DIV></DIV></DIV><DIV style="background-color: white; box-shadow: 0px 0px 4px rgba(0,0,0,0.56); border-radius: 5px; margin-top: 50px; background-color: white; padding-bottom: 40px"><DIV style="text-align: center; padding-top: 40px"><H1 style="margin: 0px auto; font-family:'Impact'; color: #337ab7">Collaborators and Supporters</H1></DIV></DIV><DIV class="container-fluid" style="border-top: 1px solid rgba(0,0,0,0.15); height: 240px; padding-top: 30px; background-color: rgb(84,146,197);"><DIV class="row" style="padding: 0px 50px"><DIV class="col-md-4"><DIV><P style="font-size: 26px; font-family:'Open-Sans-L'; color: white;">Location</P></DIV><DIV><P style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">Rm 363, Science Building</P><P style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">Xi'an Jiaotong-Liverpool University</P><P style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">111 Ren'ai Road, Suzhou, China</P><P style="line-height: 16px; font-size: 16px;font-family:'Lato-Light'; color: white;">215123</P></DIV></DIV><DIV class="col-md-4"><DIV><P style="font-size: 26px; font-family:'Open-Sans-L'; color: white;">Social</P></DIV><DIV><P style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">FB</P></DIV></DIV><DIV class="col-md-3"><DIV><P style="font-size: 26px; font-family:'Open-Sans-L'; color: white;">Get in touch</P></DIV><DIV><P style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">igem@xjtlu.edu.cn</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>